Trade trend analysis
Number of Transactions
Quantity
Weight
Number of Transactions
Quantity
Weight
The above chart presents the market trend analysis for catalent pharma solutions from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 11 transactions, with a transaction quantity of 2570.03 and a transaction weight of 0.
-
2024
58
71847.65
0
-
2025
11
2570.03
0
Bill of lading data
<
1/15
>
-
Trade date
2025/12/08
B/L No.
2552012
-
Suppliers
catalent pharma solutions
Buyers
acg pam pharma technologies pvt ltd.
-
POLs
——
PODs
mumbai (ex bombay)
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
1986.91
-
Hs code
39204900
Product tags
tap,c pen,pvc,pen,aclar,arm
-
Product description
PENTAPHARM ACLAR PA 200 S03 127 51 127 71 9400 PVC ACLAR PVC FOC PENTAPHARM PA 200 S03 127 51 127 71 9400 PVC ACLAR PVC
Expand
-
Trade date
2025/11/24
B/L No.
——
-
Suppliers
catalent pharma solutions
Buyers
jodas expoim pvt ltd.
-
POLs
——
PODs
hyderabad
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
24.23
-
Hs code
30029010
Product tags
pex,light,clone,express,mab,pert,line,gh
-
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 255 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
-
Trade date
2025/11/24
B/L No.
——
-
Suppliers
catalent pharma solutions
Buyers
jodas expoim pvt ltd.
-
POLs
——
PODs
hyderabad
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
24.23
-
Hs code
30029010
Product tags
pex,light,clone,express,mab,pert,line,gh
-
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 332 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
-
Trade date
2025/11/24
B/L No.
——
-
Suppliers
catalent pharma solutions
Buyers
jodas expoim pvt ltd.
-
POLs
——
PODs
hyderabad
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
24.23
-
Hs code
30029010
Product tags
pex,light,clone,express,mab,pert,line,gh
-
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 1708 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
-
Trade date
2025/09/01
B/L No.
2642174
-
Suppliers
catalent pharma solutions
Buyers
syngene international ltd.
-
POLs
——
PODs
biocon special economic zone (sez)
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
1000
-
Hs code
30069300
Product tags
capsule,bottle,qw
-
Product description
VQW 765 PBO CAPSULE 1CT BOTTLE UNLBLD
Expand
-
Trade date
2025/09/01
B/L No.
0636803
-
Suppliers
catalent pharma solutions
Buyers
syngene international ltd.
-
POLs
——
PODs
biocon special economic zone (sez)
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
1000
-
Hs code
30069300
Product tags
bottle,vali,mg ca,qw,ice
-
Product description
VQW 765 10MG CAPSULE 1CT BOTTLE UNLBLDLICENCE VALID UPTO 10.07.2028
Expand
-
Trade date
2025/03/26
B/L No.
3205281
-
Suppliers
catalent pharma solutions
Buyers
azurity pharmaceuticals india llp
-
POLs
——
PODs
hyderabad air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
100
-
Hs code
30049099
Product tags
fin,nilotinib,tablet,al bl
-
Product description
Nilotinib Tablets (Final blend) (FOC SAMPLES FOR R&D PURPOSEONLY)Nilotinib Tablets (Final blend) (FOC SAMPLES FOR R&D PURPOSE
Expand
-
Trade date
2025/03/06
B/L No.
2765370
-
Suppliers
catalent pharma solutions
Buyers
zenrise clinical research pvt ltd.
-
POLs
——
PODs
hyderabad air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
100
-
Hs code
30049099
Product tags
anzi,nilotinib,tablet
-
Product description
DANZITEN (nilotinib) tablets 95 mg (FOC SAMPLE FOR R&D PURPOSE ONLY)DANZITEN (nilotinib) tablets 95 mg (FOC SAMPLE FOR R&D PURPO
Expand
-
Trade date
2025/02/08
B/L No.
4535688
-
Suppliers
catalent pharma solutions
Buyers
persons /institutions /hospitals importing or expo
-
POLs
——
PODs
delhi air
-
Supply area
Germany
Purchas area
India
-
Weight
——
Amount
1726.92
-
Hs code
98041000
Product tags
car,peri,perishable cargo,vin,drug,nars,fe s,lima
-
Product description
NARSOPLIMAB (185MG/1ML)-(LIFE SAVING DRUGS) (PERISHABLE CARGO)NARSOPLIMAB (185MG/1ML)-(LIFE SAVING DRUGS) (PERISHABLE CARG
Expand
-
Trade date
2025/01/26
B/L No.
3184045
-
Suppliers
catalent pharma solutions
Buyers
vimta labs ltd
-
POLs
——
PODs
hyderabad air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
32
-
Hs code
98020000
Product tags
tartrate,nilotinib
-
Product description
NILOTINIB TARTRATE NILOTINIB TARTRATE
Expand
-
Trade date
2025/01/26
B/L No.
1411565
-
Suppliers
catalent pharma solutions
Buyers
daicel chiral technologies india pvt ltd
-
POLs
——
PODs
hyderabad air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
40
-
Hs code
29335990
Product tags
tartrate,nilotinib,rams
-
Product description
NILOTINIB TARTRATE (4 GRAMS) (FOC) NILOTINIB TARTRATE (2 GRAMS) (FOC)
Expand
-
Trade date
2024/12/03
B/L No.
8834586
-
Suppliers
catalent pharma solutions
Buyers
clinirx research pvt ltd.
-
POLs
——
PODs
bangalore air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
1644
-
Hs code
30049099
Product tags
lysi,asim,testa,igra,mill,clinical trial
-
Product description
FOR CLINICAL TRIAL-BASIMGLURANT 0.5 MILLIGRAM (MG)-FOR TESTAND ANALYSIS PURPOSE ONLY
Expand
-
Trade date
2024/12/03
B/L No.
2676233
-
Suppliers
catalent pharma solutions
Buyers
clinirx research pvt ltd.
-
POLs
——
PODs
bangalore air
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
9135
-
Hs code
30049099
Product tags
lysi,asim,testa,igra,mill,clinical trial
-
Product description
FOR CLINICAL TRIAL-BASIMGLURANT 1.0 MILLIGRAM (MG)-FOR TESTAND ANALYSIS PURPOSE ONLY
Expand
-
Trade date
2024/10/25
B/L No.
5584067
-
Suppliers
catalent pharma solutions
Buyers
vimta labs ltd
-
POLs
——
PODs
hyderabad acc
-
Supply area
United States
Purchas area
India
-
Weight
——
Amount
18.53
-
Hs code
98020000
Product tags
tartrate,nilotinib
-
Product description
NILOTINIB TARTRATE
Expand
-
Trade date
2024/10/01
B/L No.
——
-
Suppliers
catalent pharma solutions
Buyers
——
-
POLs
——
PODs
——
-
Supply area
England
Purchas area
——
-
Weight
——
Amount
——
-
Hs code
30049000
Product tags
——
-
Product description
——
Expand
+View All
Products
Total 50
-
lysi
11
10.38%
>
-
clinical trial
10
9.43%
>
-
asim
10
9.43%
>
-
mill
10
9.43%
>
-
igra
10
9.43%
>
+View All
Hscode rank
Total 227
-
HS 30049099
21
19.81%
>
-
HS 30049000
21
19.81%
>
-
HS 30043900
7
6.6%
>
-
HS 76072099
6
5.66%
>
-
HS 98020000
5
4.72%
>
+View All
Port statistics
Total 46
-
philadelphia
176
6.90%
>
-
miami
115
4.51%
>
-
naples
50
1.96%
>
-
narita apt tokyo
38
1.49%
>
-
bremerhaven
29
1.14%
>
+View All
catalent pharma solutions is england Buyer&Supplier,
and primarily engages in the import and export business of products such as lysi,clinical trial,asim.
According to the 52wmb.com global trade database, as of 2025-12-08, the company has completed 2551 international trades,
The core products include HS30049099,HS30049000,HS30043900 etc,
often transported via philadelphia,port miami, port naples etc,
and its main trading partners are novartis biosciences peru s.a.,wyeth s.a.,тов ворлдвайд клінікал траілс укр.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on catalent pharma solutions is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.